Gland Pharma Limited
Track this name
Business & moat
Business Snapshot
Moat Analysis
Moat anchored in scale-based cost advantages and regulatory barriers, but commoditized generic base limits durability.
Performance & outlook
Quarterly Score
Growth Prospects
FY27 base-case growth 12-13%
Management & drivers
Guidance Tracker
Key Variables
Capacity utilization — Capacity utilization has steadily improved across key lines, driving operating leverage and margin expansion. Near-full utilization in certain lines is triggering new capex, indicating demand visibility. Cenexi's Fontenay site reached full capacity, justifying